|
CPEB3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63302704692114E-12 |
| Normal-vs-Stage2 |
1.50229999995588E-07 |
| Normal-vs-Stage3 |
1.27939991934056E-10 |
| Normal-vs-Stage4 |
7.11009999987411E-07 |
| Stage1-vs-Stage2 |
8.579000E-01 |
| Stage1-vs-Stage3 |
1.419010E-01 |
| Stage1-vs-Stage4 |
3.668600E-01 |
| Stage2-vs-Stage3 |
1.863430E-01 |
| Stage2-vs-Stage4 |
2.700000E-01 |
| Stage3-vs-Stage4 |
9.485400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
9.15380005128696E-09 |
| Normal-vs-Asian |
6.045000E-04 |
| Caucasian-vs-AfricanAmerican |
2.102100E-02 |
| Caucasian-vs-Asian |
9.224000E-01 |
| AfricanAmerican-vs-Asian |
4.262400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
5.45420042463718E-10 |
| Male-vs-Female |
4.145200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.24919963262471E-10 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
2.00119920634734E-11 |
| Normal-vs-Extreme_Obese |
6.381600E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.976400E-01 |
| Normal_Weight-vs-Obese |
3.642600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.061500E-02 |
| Extreme_Weight-vs-Obese |
2.261000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.523200E-01 |
| Obese-vs-Extreme_Obese |
1.629000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.23510000005211E-07 |
| Normal-vs-Age(41-60Yrs) |
4.34985381048136E-13 |
| Normal-vs-Age(61-80Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(81-100Yrs) |
1.04050001947797E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.575400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.986600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.297800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.406800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.310300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.063800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62481139653892E-12 |
| Normal-VS-Type2 PRCC |
1.40887301824932E-13 |
| Normal-VS-KIRP CIMP |
1.55497836828999E-12 |
| Normal-VS-Unclassified PRCC |
1.19470000004007E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.042430E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.197700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.201800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.895920E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.431700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.180200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.61268784385038E-12 |
| Normal-vs-N1 |
3.47200046491025E-11 |
| Normal-vs-N2 |
3.67009999999723E-05 |
| N0-vs-N1 |
3.807400E-01 |
| N0-vs-N2 |
7.453900E-02 |
| N1-vs-N2 |
2.409600E-01 |
|
|
